News | April 28, 2022
Thermo Fisher Scientific expands R&D facility in Hyderabad
This facility will design & develop instruments, perform product reliability performance testing and verification
This facility will design & develop instruments, perform product reliability performance testing and verification
This is the first major brand refresh of CanSinoBIO since its inception in 2009
A separate global Phase 3 study of S-217622 is underway aiming to recruit participants globally to support regulatory filings this year
Strive to empower public health with disinfection robotics solutions in post-pandemic era
The life sciences and pharmaceutical sectors suffer from hard-to-source biological materials, which translates into high costs in research and development
Tc99m tilmanocept is designed for the precise identification of lymph nodes that drain from a primary tumor, which have the highest probability of harboring cancer
The data driven fertility company helps increase the success rate of fertility treatments
The US $600 million acquisition will see Juniper Biologics offer the world's first cell-mediated gene therapy to an estimated 300 million patients in Asia Pacific, Middle East and Africa
It supports advanced research and helps scientists accelerate potential cures, drug discoveries and diagnostics research
The company plans to file its NDA in China and MAA in the EU in 2022, making Hansizhuang potentially to be the world's first PD-1 inhibitor for the first-line treatment of SCLC
Subscribe To Our Newsletter & Stay Updated
